Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Arcadia Biosciences, Inc. (RKDA : NSDQ)

• Company Description    Arcadia Biosciences Inc. is a producer and marketer of plant-based health and wellness products. Arcadia Biosciences Inc. is based in DALLAS. Number of Employees: 9

• Price / Volume Information    Yesterday's Closing Price: $1.98 Daily Weekly Monthly 20 Day Moving Average: 22,131 shares Shares Outstanding: 1.37 (millions) Market Capitalization: $2.72 (millions) Beta: 0.57 52 Week High: $6.36 52 Week Low: $1.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -45.75% -45.66% 12 Week -51.47% -52.25% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5956 Sherry Lane Suite 2000 - Dallas,TX 75225 USA ph: 214-974-8921 fax: 530-756-7027 ir@arcadiabio.com http://www.arcadiabio.com

• General Corporate Information    Officers Thomas J. Schaefer - President and Chief Executive Officer Mark Kawakami - Chief Financial Officer Albert D. Bolles - Director Kevin Comcowich - Director Lilian Shackelford Murray - Director Peer Information Arcadia Biosciences, Inc. (CORR.) Arcadia Biosciences, Inc. (RSPI) Arcadia Biosciences, Inc. (CGXP) Arcadia Biosciences, Inc. (BGEN) Arcadia Biosciences, Inc. (GTBP) Arcadia Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 039014303 SIC: 1311 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/19/26 Share - Related Items Shares Outstanding: 1.37 Most Recent Split Date: 3.00 (0.03:1) Beta: 0.57 Market Capitalization: $2.72 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/19/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.50 Price/Cash Flow: - Price / Sales: 0.53 EPS Growth vs. Year Ago Period: 171.26% vs. Previous Quarter: 3,000.00% Sales Growth vs. Year Ago Period: -15.29% vs. Previous Quarter: -10.52% ROE 12/31/25 - - 09/30/25 - -8.80 06/30/25 - -34.75 ROA 12/31/25 - - 09/30/25 - -5.15 06/30/25 - -20.91 Current Ratio 12/31/25 - - 09/30/25 - 3.67 06/30/25 - 4.12 Quick Ratio 12/31/25 - - 09/30/25 - 3.03 06/30/25 - 3.31 Operating Margin 12/31/25 - - 09/30/25 - -10.67 06/30/25 - -47.90 Net Margin 12/31/25 - - 09/30/25 - -97.97 06/30/25 - -139.36 Pre-Tax Margin 12/31/25 - - 09/30/25 - -97.31 06/30/25 - -130.77 Book Value 12/31/25 - - 09/30/25 - 3.98 06/30/25 - 3.32 Inventory Turnover 12/31/25 - - 09/30/25 - 2.51 06/30/25 - 2.98 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©